A New Resorbable Magnesium Scaffold for de Novo Coronary Lesions (DREAMS 3G): One-Year Results of the BIOMAG-1 First-In-Human Study

Published: 01 Sep 2023

  • Views:

    Views Icon 329
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

In this interview, Prof Michael Haude (Rheinlandklinkum, DE) explains the DREAMS 3G device, what the BIOMAG-I study is and what impact this has on the data for the future of scaffolds.

This video is supported by


You must be to comment. If you are not registered, you can register here.